Home-Page-Slides-Images_1.jpg

The RIGHT Treatment

The FIRST Time

Powered by the PREDICTIX Artificial Intelligence Mental Health Platform

630M

People globally suffer with mental health disorders

$2.5 T

Global annual costs for mental health

No.1

Depression is the leading cause of disability worldwide

50%

Of patients do not achieve complete relief from their initial antidepressant.

Advancing the Treatment of Mental Health

AI Empowering Mental Health

Prescribing Decisions

and Follow-up

Mental health conditions are highly complex and affect each of us uniquely. Their successful treatment depends on understanding the relationships between patients’ genetic, metabolic, demographic and clinical information. 

The PREDICTIX mental health platform uses AI to translate this complex data into an easy-to-use assessment and validation software to empower patient prescribing decisions and follow-up.

They have chosen PREDICTIX

Partner With Us

Payers & Providers
Telemedicine 
Providers
Labs
Medical Distributors
CONTACT US

Tel: +972 (0)77 335 2506

Fax: +972 (0)3 650 5594

office@taliazhealth.com

2 Prof. Yehezkel Kaufmann St.

(15th Floor), Tel Aviv-Yafo, Israel

  • LinkedIn
  • Twitter
  • Facebook
PREDICTIX_Logo_Dark.png

Disclaimer: Taliaz is developing the PREDICTIX Genetics and PREDICTIX Digital products. PREDICTIX (Genetics) Antidepressant is currently available for commercial use in the EU and Israel. Outside of the EU and Israel, PREDICTIX Genetics products are currently limited by law for investigational use only. PREDICTIX Digital products are currently limited by law for investigational use only. 

Copyright © 2020 PREDICTIX by TALIAZ Ltd. All Rights Reserved